Kimberly Bjugstad

3 weeks ago | medcentral.com | Kimberly Bjugstad

Genes associated with psychiatric disorders do not guarantee nor do they diagnose psychiatric illness. Yet, these misconceptions are prevalent among clinicians and patients. Genetic testing initially sought to diagnose psychiatric disorders in the same way some medical disorders are diagnosed, however, as Jehannine Austin, PhD, told MedCentral, “We may never be able to do that.

1 month ago | medcentral.com | Kimberly Bjugstad

A new international consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors was published online last month in Annals of the Rheumatic Diseases, providing a key update to the prior 2019 statement.1,2 Put together by an international committee of rheumatology experts, the new statement provides a much-needed update given that several new Janus kinase inhibitors (JAKi) have been approved since 2019, many of them being indicated for...

2 months ago | medcentral.com | Kimberly Bjugstad

“I feel burned out from my work” was the primary outcome measure in a recent study that sought to understand physician burnout as a function of managing the health-related social needs of patients.1 The bottom line found by Tabata-Kelly et al., which was published recently in JAMA Network Open, was that the more physicians help patients tackle their social needs, the greater their risk of burnout (P < 0.05).1 However, the researchers also uncovered some interesting trends that could help...

2 months ago | medcentral.com | Kimberly Bjugstad

More than three out of five healthcare workers reported mental health challenges during the COVID-19 pandemic,1 with causes tied to a lack of adequate staffing, increasing job demands, and burnout. But, said Anthony Papa, PhD, “these have been important workplace stressors for healthcare workers for some time.” Dr. Papa is an associate professor and director of clinical training in psychology at the University of Hawai'i at Mānoa.

Oct 28, 2024 | medcentral.com | Kimberly Bjugstad

Schizophrenia has historically been treated as a dopamine-based disorder, however a novel therapeutic is encouraging clinicians to rethink the dopamine hypothesis.